Skip to main content

Find Clinical Trials

Home
Conditions
RNA Virus Infections

Clinical trial condition

RNA Virus Infections

Explore clinical trials studying RNA Virus Infections. Study availability and eligibility vary by location and protocol.

80 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

RNA Virus Infections trial results

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

NCT01851330

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +17 more
Locations: Birmingham, Alabama, United States

La Jolla, California, United States

Los Angeles, California, United States

Palo Alto, California, United States

View all 52 locations

View Trial Details

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

NCT01768286

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +17 more
Locations: Phoenix, Arizona, United States

Tucson, Arizona, United States

La Jolla, California, United States

Los Angeles, California, United States

View all 53 locations

View Trial Details

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

NCT01701401

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +17 more
Locations: Birmingham, Alabama, United States

La Jolla, California, United States

Long Beach, California, United States

Los Angeles, California, United States

View all 88 locations

View Trial Details

Completed

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

NCT02098616

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: VA Long Beach Healthcare System Long Beach, California, United States

View Trial Details

Completed

Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV

NCT01946594

Conditions: Body Temperature Changes, Fever, Infections, +8 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

NCT02630082

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.

NCT02022163

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Canadian Science Centre for Human and Animal Health Winnipeg, Manitoba, Canada

View Trial Details

Completed

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

NCT01838590

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +17 more
Locations: Al Mansurah, Egypt

Cairo, Egypt

View Trial Details

Completed

DNA-based Influenza Vaccine in the Elderly

NCT01587131

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: MS Building Health Sciences Centre Winnipeg, Manitoba, Canada

View Trial Details

Completed

Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms

NCT01641094

Conditions: Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +26 more
Locations: Reinier de Graaf Ziekenhuis Delft, South Holland, Netherlands

Erasmus Medical Center Rotterdam, Netherlands

View Trial Details